• SENSEX
    NIFTY 50

Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin

Updated : December 22, 2020 02:40 PM IST

According to the company, the vaccine is developed and manufactured at Bharat Biotech’s BSL-3, biocontainment facility.
The company has successfully recruited 13,000 volunteers for the Phase III clinical trials of the vaccine.
The target is to have 26,000 participants.
Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin
Published : December 22, 2020 02:40 PM IST

You May Also Like

Live TV

recommended for you

Advertisement